Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

TRoMbone is a pilot study assessing feasibility to randomise men with newly presenting oligometastatic prostate cancer that has spread to the bone, to either standard systemic therapy or that same standard care plus radical prostatectomy. It aims to recruit 50 men by Aug 19, 2018, and is funded by the Prostate Cancer Foundation and The Urology Foundation.